Piper Sandler Reiterates Overweight on Omnicell, Lowers Price Target to $45
Piper Sandler analyst Jessica Tassan reiterates Omnicell (NASDAQ:OMCL) with a Overweight and lowers the price target from $55 to $45.
Read original at benzingaStocks · News reference
Wells Fargo Maintains Overweight on Omnicell, Lowers Price Target to $50
Wells Fargo analyst Stan Berenshteyn maintains Omnicell (NASDAQ:OMCL) with a Overweight and lowers the price target from $55 to $50.
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Jul 31, 2026, 2:30 PM
- Checked
- Jul 31, 2026, 2:30 PM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading